Friday, January 10, 2025
spot_img
More

    Latest Posts

    Ibrutinib Safe and Effective in Patients With CLL/SLL, Real-World Data Show 

    The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

     

    Latest Posts

    spot_imgspot_img

    Don't Miss